Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Interactive Cardiovascular and Thoracic Surgery|March 23, 2017
Left sinus of Valsalva aneurysm as a cause of chronic stable anginaAlexandre Ponti, Salah D Qanadli, Matthias Kirsch, et al.
Revue Medicale Suisse|March 3, 2021
[Heart and thromboembolic events: situation in 2021]Bojan Djokic, Grégoire Girod, Maxime Tapponnier, et al.
Revue Medicale Suisse|March 3, 2021
[Heart failure in year 2021: a review for the general practitioner]Michele Vivaldo, Raluca Alexe, Christophe Sierro, et al.
Revue Medicale Suisse|July 5, 2017
[News about pericardial diseases in 2016]Baris Karpuz, Valèrie Duchatelle, Maxime Tapponnier, et al.
Intensive Care Medicine|July 18, 2006
Time course of lung injury in rat acute pancreatitisDenis R Morel, Jean-Louis Frossard, Banu Cikirikcioglu, et al.
Revue Medicale Suisse|February 28, 2022
[The influence of summer temperatures on the incidence of Takotsubo cardiomyopathy : a retrospective study]Valérie Duchatelle, Sébastien Delhasse, Baris Karpuz, et al.
Revue Medicale Suisse|January 22, 2013
[Cell-based regenerative therapy in cardiology: the future at present]Juan F Iglesias, Maxime Tapponnier, Roger Hullin, et al.
American Journal of Respiratory and Critical Care Medicine|July 5, 2003
Functional identification of the alveolar edema reabsorption activity of murine tumor necrosis factor-alphaNadia Elia, Maxime Tapponnier, Michael A Matthay, et al.
American Heart Journal|May 16, 2023
Ultrathin-strut vs thin-strut drug-eluting stents for multi and single-stent lesions: A lesion-level subgroup analysis of 2 randomized trialsJonas D Häner, Miklos Rohla, Sylvain Losdat, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 6, 2017
A comparison of an ultrathin-strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: rationale and design of the BIOSTEMI trialJuan F Iglesias, Olivier Muller, Serge Zaugg, et al.
Pageof 2